Autobacs Seven Co (9832) Stock Statistics & Valuation Metrics

Autobacs Seven Co has a market cap or net worth of ¥114.10B. The enterprise value is ¥120.81B.

Autobacs Seven Co has 82,050,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Autobacs Seven Co’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.26%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Autobacs Seven Co had revenue of 249.53B and earned 8.13B in profits. Earnings per share was 103.89.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Autobacs Seven Co pays an annual dividend of ¥30, resulting in a dividend yield of 4.1%

Autobacs Seven Co upcoming earnings date is ―, ―.

Autobacs Seven Co as a current ratio of 2.17, with Debt / Equity ratio of 28.69%

In the past 12 months, Autobacs Seven Co has paid 4.80B in taxes.

Autobacs Seven Co EV to EBITDA ratio is 6.51, with an EV/FCF ratio of -25.02.

Autobacs Seven Co has ¥33.39B in cash and marketable securities with ¥23.42B in debt, giving a net cash position of -¥9.97B billion.

Gross margin is 35.42%, with operating margin of 4.86%, and net profit margin of 3.26%.

The average price target for Autobacs Seven Co is ¥1,604.07, which is 11.43% higher than the current price. The consensus rating is Moderate Buy